An NCI-designated Comprehensive Cancer Center
Susan Brown, SVP, Patient Care Services and Chief Nursing Officer and Team
City of Hope provides cancer support services to Amazon employees
October 15, 2019 | by Zen Vuong
City of Hope is partnering with Amazon to provide a range of enhanced cancer support services to the company’s employees in the U.S. — including a dedicated phone line staffed by oncology nurses, specialized support for complex cancers, and diagnosis and treatment plan review.
Patient Care
Kuk Promo Shot
Kuk Harrell: His caregivers speak
October 10, 2019 | by Malcolm Bedell
In honor of Kuk Harrell’s role as a patient speaker at City of Hope’s 2019 Spirit of Life gala, we caught up with the members of his care team for their perspective and insights on the Grammy winner’s cancer journey.
Patient Care
brain tumor
Novel immunotherapy combo featured in new trial for recurrent glioblastoma
October 10, 2019 | by Letisia Marquez
City of Hope has opened a first-in-human clinical trial for patients with recurrent glioblastoma – the trial is the first to combine City of Hope’s unique CAR T cell therapy with immune checkpoint inhibitors.
Research | Patient Care
Kandace McMenomy Hero | City of Hope
Meet Kandace McMenomy, 2019 Walk for Hope Ambassador
October 3, 2019 | by Michael Easterling
An avid marathon runner, health fanatic and adventurer, Kandace McMenomy never dreamed she'd be adding “cancer patient” to her personal description. But she was diagnosed with Stage 2 estrogen-positive breast cancer at just age 30.
Community | Patient Care
Chen-Shiuan
Superfoods Researcher Receives $3.3M Grant for Mushroom Study
October 3, 2019 | by C. Pete Lee
Shiuan Chen, Ph.D., who heads City of Hope’s Natural Therapies Program, is studying the effects of white button mushrooms on prostate cancer patients. He previously found that phytochemicals in mushrooms had the ability to block the activity of an enzyme that contributes to breast cancer.
Research
Larry Kwak
CAR T cell therapy targeting new receptor proves effective for relapsed CAR T patients
September 25, 2019 | by Letisia Marquez
City of Hope’s research on the new CAR T therapy, published in Science Translational Medicine, offers hope for patients who have relapsed after commercially available CD19 immunotherapy treatments.
Research